Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PDL-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02659384
What this trial is testing

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
European Organisation for Research and Treatment of Cancer - EORTC 122
Large-scale testing (Phase 3)UnknownNCT05322187
What this trial is testing

Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy

Who this might be right for
Transitional Cell TumorHepatoblastomaLiver Cancer+2 more
RenJi Hospital 15
Testing effectiveness (Phase 2)UnknownNCT03732508
What this trial is testing

SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer

Who this might be right for
Advanced Esophageal Squamous Cell Cancer
Jiangsu HengRui Medicine Co., Ltd. 30
Not applicableLooking for participantsNCT06849518
What this trial is testing

Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)
Ballad Health 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03697850
What this trial is testing

Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy

Who this might be right for
Bladder Cancer
UNICANCER 79
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07554768
What this trial is testing

Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaLocally Advanced Head and Neck Squamous Cell Carcinoma
Chen Chunyan 36
Testing effectiveness (Phase 2)UnknownNCT04215471
What this trial is testing

NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma

Who this might be right for
Oesophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 30
Large-scale testing (Phase 3)Ended earlyNCT05149807
What this trial is testing

Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer

Who this might be right for
Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 81
Testing effectiveness (Phase 2)Study completedNCT04115111
What this trial is testing

Diadem to Investigate the Activity and Safety of Durvalumab

Who this might be right for
Pleura Mesothelioma
Mario Negri Institute for Pharmacological Research 57
Not applicableUnknownNCT06402981
What this trial is testing

A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients

Who this might be right for
Immune Checkpoint InhibitorsLiver Injury
Zhejiang University 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT07100392
What this trial is testing

Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab

Who this might be right for
Hepatocellular Carcinoma (HCC)
Fudan University 141
Testing effectiveness (Phase 2)WithdrawnNCT03212807
What this trial is testing

Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL

Who this might be right for
EBV Related Non-Hodgkin's LymphomaPrimary CNS LymphomaPrimary Testicular Lymphoma
Singapore General Hospital
Large-scale testing (Phase 3)Active Not RecruitingNCT05239728
What this trial is testing

Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 1,800
Not applicableLooking for participantsNCT06475807
What this trial is testing

Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
Cancer
University of Pittsburgh 70
Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Early research (Phase 1)Study completedNCT03801902
What this trial is testing

Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaLocally Recurrent Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8+2 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Ended earlyNCT03024437
What this trial is testing

Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Metastatic CancerRenal Cancer
Roberto Pili 31
Early research (Phase 1)Not Yet RecruitingNCT07430202
What this trial is testing

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Who this might be right for
Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Testing effectiveness (Phase 2)Looking for participantsNCT07400302
What this trial is testing

Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery

Who this might be right for
Mucosal MelanomaPD-L1 Positive
The First Hospital of Jilin University 220
Testing effectiveness (Phase 2)Looking for participantsNCT04198766
What this trial is testing

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more
Inhibrx Biosciences, Inc 340
Next Page